PESI, Inc. Logo

Continuing Education Seminars, CDs, DVDs, Publications, and Online


Preview

Buy It

  • Downloadable MP4 Video and MP3 Audio
    Course ID: PPC045575
    Credit Type: Self-Study
    $299.99

Rent It

  • Streaming Video
    Course ID: POS045575
    Credit Type: Self-Study
    $179.99

2013 Psychopharmacology Conference

Length: 2 days

Additional Participant CE:
$29.99

Rent It Access:
30 days from purchase

CD/DVD:

Click here to purchase the DVD or CD recording from our product store.

Description

  • Proposed DSM-5® and psychotropics
  • Alternative Remedies & Herbals
  • Brand vs. generic…When to switch
  • Contemporary trends in medication management
  • Diagnostic fads in youth and controversies surrounding drug use

Join author and expert, Joe Wegmann, Doctor of Pharmacy, LCSW, to find out the latest information on psychopharmacology and enhance your knowledge of psychiatric medications. Throughout the conference you will also be asked to interpret more controversial aspects of psychotropic medication and why drug treatment is overrated, ineffective or unnecessary for select clinical conditions. After attending both days of this psychopharmacology conference you will have a comprehensive understanding of the most frequently prescribed psychotropic medication classes – placing you in a better position to improve client outcomes.

The conference includes an examination of the medication management of unipolar depression, bipolar disorder and anxiety. The clinical uses, mechanisms of action, side effects, benefits, safety factors and controversies of psychotropics will be discussed. You’ll be given tips for resolving medication challenges associated with generic vs. brand drugs, polypharmacy and relationships with physicians.

Major psychotic spectrum disorders and how antipsychotic medications work will be covered as we look back at first and second generations of antipsychotics and the growing landscape of these medications. In addition, you will learn the risk factors and side effects associated with antipsychotics and the expectations of attaining recovery from schizophrenia.

Additionally, you will learn vital information about the safety and efficacy track record of psychotropics in specific populations – expectant mothers, youth and the elderly. This information includes benefits, risks and divergent views associated with drug use in each of these special groups.

You will find Joe Wegmann’s conference to have the most up to date medication information and how to use it most effectively for your client.

DAY ONE OUTLINE

MAKING A MEDICATION REFERRAL

  • The trinity: Observe, Listen, Ask
  • Questions clients should be asking their prescribers

BIOLOGICAL PSYCHIATRY

  • Neurotransmitters: Norepinephrine, serotonin, dopamine, GABA
  • Reasons why neuroscience is more fascinating than practical

DEPRESSION

  • Unipolar Depression
    • Why depression is not a diagnosis
  • Discussion of the “cause and effect”
  • Assessing depression, what’s important, what’s not
  • Influences: Reactive, biological, medical, hormonal, substance abuse
    • Depression as a clinical condition has become diluted

ANTIDEPRESSANT MEDICATIONS

  • How they work? Do they work ?
  • Why neurotransmitter manipulation is a dicey proposition
  • Are they any better than placebos for most users?
  • Classes of Antidepressants:
    • Cyclic, SSRIs, SNRIs, NRIs, DNRIs, others
    • Why they’re prescribed for the wrong symptom set
  • Antidepressant selection – the 5-step plan
    1. How the depression presents
    2. Family history
    3. Drug characteristics
    4. Reasonable expectations
    5. Integrated recovery
  • Side effects, risk factors, non compliance, dosing
  • “My antidepressant isn’t working the way it used to.” Have you heard that one before? Why this is

IF THE DEPRESSION CONTINUES, THEN WHAT?

  • Augmentation strategies: Additive or combination protocols
  • Mechanical strategies: ECT, transcranial magnetic stimulation

HERBALS AND ALTERNATIVE REMEDIES FOR DEPRESSION

  • St. John’s Wort, Omega 3s, Vitamin D3, SAM-e
  • Alternative remedies to avoid

BIPOLAR SPECTRUM DISORDERS

  • Diagnosis is all over the place and so is medication management
  • Is there really such a thing as a distinct manic phase and a distinct depressive phase?
  • Mania: A mnemonic for the manic markers
  • Bipolar depression: How to differentiate from unipolar
  • Bipolar I and Bipolar II classifications are obsolete
  • Diagnosing bipolar disorder – index it
  • Myriad drug options: Lithium, anticonvulsants, new antipsychotics
  • Recent advances
  • Treatment-resistant bipolar: A formidable foe
  • Medication side effects, non compliance, risk factors, dosing
  • As Dr. House was fond of saying: “Everybody lies.” The importance of collateral information when assessing for this disorder

TIPS FOR RESOLVING PSYCHOTROPIC DRUG DILEMMAS

  • Generic vs. Brand medications
  • Polypharmacy: Friend or foe?
  • Forming strong alliances with prescribers

DAY TWO OUTLINE

THE MANY MANIFESTATIONS OF ANXIETY:

  • Panic, GAD, OCD, PTSD
  • Worry vs. concern
  • Medicating anxiety: What works best; what shouldn’t be medicated
  • Benzodiazepines
  • Non benzodiazepines: Buspar, antihistamines
  • Rational approaches for managing insomnia and the placebo effect
  • Sleep agents: Ambien, Lunesta, melatonin
  • The micromanagement of insomnia: The new drug Intermezzo for early morning awakenings
  • Side effects of the anxiolytics and sleep agents

MAJOR PSYCHOTIC SPECTRUM DISORDERS

  • The primary psychoses
  • Symptom domains of schizophrenia
  • How antipsychotics work: The dopamine model
  • First generation antipsychotics
    • Thorazine, Haldol – still alive and kicking
  • Second generation antipsychotics
    • Clozaril, Risperdal, Zyprexa, et al.
    • Ten of these all together; five too many
  • Unapproved use of antipsychotics: A growing concern
  • Is recovery attainable in schizophrenia; relapse issues
  • Side effects, risk factors; poison and mind control issues

SPECIFIC POPULATION GROUPS

  • Expectant mothers
    • Recent changes in psychotropic medication guidelines during pregnancy: a detailed discussion
    • There’s no such thing as a safe drug during pregnancy
  • Older adults
    • Aging and mental health
    • Dosing concerns; safety issues; “self-medication” issues, mental status changes
    • Interventions to promote successful aging
  • Children and adolescents
    • What’s new in child and adolescent psychopharmacology? Not much
    • Maturational issues
    • Nature vs. nurture when it comes to diagnosing mood disorders
    • Depression, bipolar, anxiety, psychosis in youth
    • Why medication management is unpredictable and controversial
    • The veritable explosion of bipolar diagnosis in youth
    • Disruptive Mood Dysregulation Disorder: A setback for child psychiatry
    • ADHD and its new treatment guidelines
    • Medication use for ADHD – stimulants, non stimulants, antidepressants, anti-hypertensives
    • Side effects
    • Dosing and drug holidays

DSM-5® AND PSYCHOTROPIC MEDICATION USE

  • Will we all be deemed psychiatrically sick?
  • Over-medicalization and runaway psychotropic drug use

TIPS FOR RESOLVING PSYCHOTROPIC DRUG DILEMMAS

  • Overcoming psychotropic medication resistance
  • 5 key reasons for non compliance and how you can help

DAY ONE OBJECTIVES

  • Address the key components associated with making a psychotropic medication referral.
  • Identify the clinical uses and various classes of antidepressants, how they work and their common side effects.
  • Explain the process of initiating antidepressant selection.
  • Examine the role of herbals and alternative remedies in the treatment of depression.
  • Integrate the use of the new diagnostic paradigm – the Bipolarity Index – into your assessment of bipolar disorder.
  • Discuss the myriad medication options for treating bipolar disorder.
  • Describe techniques and interventions for resolving common psychotropic medication dilemmas.

DAY TWO OBJECTIVES

  • Identify safe and effective medication approaches for anxiety and insomnia.
  • Examine the psychotic spectrum disorders and contrast the use of the first and second generation antipsychotics.
  • Discuss the appropriate and controversial use of psychotropics in youth with depression, bipolar, anxiety and psychosis.
  • Understand how ADHD is best treated pharmacologically.
  • Address the most recently published guidelines for psychotropic use during pregnancy.
  • Describe the challenges and concerns of psychotropic use with older adults.
  • Learn effective strategies for resolving medication resistance and fostering drug compliance.

ABOUT THE SPEAKER

Joseph Wegmann, Doctor of Pharmacy, LCSW is a licensed clinical social worker and a Doctor of Pharmacy specializing in psychopharmacology. He has presented psychopharmacology seminars to thousands of healthcare professionals throughout 46 states, and he maintains an active psychotherapy practice specializing in the treatment of depression and anxiety. He is extensively published in the field of psychopharmacology having contributed to numerous clinical newsletters and professional journals across the country. Dr. Wegmann is a contributing writer for Social Work Today, and has an ongoing blog with the prestigious Psychology Today. Joe’s latest book, Psychopharmacology: Straight Talk on Mental Health Medications, is available at pesi.com. Explore Joe’s programs at www.pharmatherapist.com, or write him at joe@thepharmatherapist.com. Joe has served as adjunct professor of psychopharmacology in the Southern University of New Orleans master of social work program for 17 years.


To order the book, Psychopharmacology: Straight Talk on Mental Health, please visit our bookstore.

To order the books, Psychopharmacology Pocket Guides, please visit our bookstore.


TARGET AUDIENCE

Psychologists, Counselors, Social Workers, Case Managers, Addiction Counselors, Marriage & Family Therapists, Nurses and other Mental Health Professionals

ADA NEEDS

Premier Education Solutions would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 800-844-8260.


Credit Information

NOTE: Tuition includes one free CE Certificate. Additional certificates are available for $29.99. Please contact our Customer Service at 1-800-844-8260 for more details.

Continuing Education Information:  This activity qualifies for continuing education for the following professionals in every state: Psychologists, Counselors, Social Workers, Case Managers, Addiction Counselors, Marriage & Family Therapists, Nurses and other Mental Health Professionals. For states that differ from national board approval see details below. For states not listed or do not accept national approvals please contact CMI or your licensing board.

CE Information is based on 100% attendance.

PSYCHOLOGISTS: CMI Education Institute, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. CMI maintains responsibility for this program and its content. CMI is offering this activity for 12.0 live or 11.5 self-study hours of continuing education credit. Full attendance is required; no partial credits will be offered for partial attendance.

SOCIAL WORKERS:  CMI Education Institute, Provider #1062, is approved as a provider for continuing education by the Association of Social Work Boards, 400 South Ridge Parkway, Suite B, Culpeper, VA 22701. www.aswb.org. ASWB Approval Period: January 27, 2014-January 27, 2017. Social workers should contact their regulatory board to determine course approval. Social workers will receive 12.0 live or 11.75 self-study (Clinical) continuing education clock hours in participating in this activity after successful completion of the post test/evaluation form. Course Level: All Levels.

FLORIDA SOCIAL WORKERS/MARRIAGE & FAMILY THERAPISTS/MENTAL HEALTH COUNSELORS:  CMI Education Institute, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number BAP #77. This course qualifies for 12.0 live or 11.75 self-study continuing education credits.

After completing and passing the online post-test/evaluation, please contact cecmi@cmieducation.org to have your credits reported to CE Broker. You will need to provide the full title of the webcast, date of live broadcast, your name and your license number in the email.

ILLINOIS SOCIAL WORKERS: CMI Education Institute is an approved provider with the State of Illinois, Department of Professional Regulation. License #: 159-000154. Full attendance at this activity qualifies for 12.0 live or 11.5 self-study contact hours.

MINNESOTA SOCIAL WORKERS:  CMI Education Institute, Inc. is an approved provider with the State of Minnesota, Board of Social Work. Provider #:  CEP-140. This course has been approved for 12.0 live or 11.5 self-study continuing education hours. This certificate has been issued upon successful completion of a post-test.

COUNSELORS: CMI Education Institute, Inc, is an approved provider of the National Board of Certified Counselors, NBCC Provider #: 5637. We adhere to NBCC Continuing Education Guidelines. This activity qualifies for 12.0 live or 11.75 self-study contact hours.

CALIFORNIA COUNSELORS/SOCIAL WORKERS/MARRIAGE & FAMILY THERAPISTS/LICENSED EDUCATIONAL PSYCHOLOGISTS: CMI Education Institute, Inc. is an approved provider with the State of California, Board of Behavioral Sciences, Provider #: 2087. Full attendance at this course meets the qualifications for 12.0 live or 11.0 self-study hours of continuing education credit as required by the California Board of Behavioral Sciences.

OHIO COUNSELORS/SOCIAL WORKERS/MARRIAGE & FAMILY THERAPISTS: CMI Education Institute is an approved provider with the State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board. Provider approval #:RCST071001. Full attendance at this course meets the qualifications for 12.0 live or 11.75 self-study clock hours of continuing education credit.

ADDICTION COUNSELORS: CMI Education Institute is an approved provider of continuing education by the National Association of Alcoholism & Drug Abuse Counselors (NAADAC), provider #: 00131. Full attendance is required; no partial credit will be awarded for partial attendance. This activity qualifies for 14.0 live or 14.0 self-study contact hours.

CALIFORNIA ALCOHOLISM & DRUG ABUSE COUNSELORS:  CMI Education Institute, Inc. is an approved provider with the California Association of Alcoholism and Drug Abuse Counselors (CAADAC) Provider #:  OS-03-036-1013. This course meets the qualifications for 12.0 live or 11.0 self-study hours of continuing education credit.

MARRIAGE AND FAMILY THERAPISTS: This activity consists of 720 live minutes or 11.75 self-study clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the activity advertisement, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.

ILLINOIS MARRIAGE & FAMILY THERAPISTS:  CMI Education Institute has been approved as a provider of continuing education by the State of Illinois, Department of Professional Regulation. Provider #:  168-000156. Full attendance at this activity qualifies for 12.0 live or 11.5 self-study credits. 

TEXAS MARRIAGE & FAMILY THERAPISTS:  CMI Education Institute has been approved as a continuing education sponsor through the Texas State Board of Examiners of Marriage and Family Therapists. Provider #: 503. This activity qualifies for 12.0 live or 11.5 self-study continuing education credits.

NURSES/NURSE PRACTITIONERS/CLINICAL NURSE SPECIALISTS: This activity meets the criteria for an American Nurses Credentialing Center (ANCC) Activity. CMI Education Institute, Inc, is an approved provider by the American Psychological Association, which is recognized by the ANCC for behavioral health related activities. Full attendance is required. No partial credit will be offered for partial attendance.

This activity qualifies for 12.0 live or 11.5 self-study contact hours.

CALIFORNIA NURSES:  CMI Education Institute, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number 13305 for 12.0 live or 11.0 self-study contact hours. Full attendance is required. No partial contact hours will be issued for partial attendance.

FLORIDA NURSES: CMI Education Institute, Inc. is an approved provider with the Florida Board of Nursing, Provider # FBN2858. This course qualifies for 12.0 live or 11.8 self-study contact hours.

Contact cecmi@cmieducation.org to have your credits reported to CE Broker. You will need to provide your name and license number in the email.

IOWA NURSES:  CMI Education Institute, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Full attendance at this activity qualifies for 14.4 live or 14.3 self-study contact hours. Full attendance in the activity is required; no partial contact hours will be issued for partial attendance. These contact hours are used for your license renewal.

NURSE PRACTITIONERS: This program offers 720 live or 690 self-study instructional minutes of pharmacology content which is designed to qualify for 12.0 live or 11.5 self-study contact hours toward your pharmacology requirement to receive credit. It is your responsibility to submit your certificate of successful completion and a copy of the seminar brochure to your licensing board.

OTHER PROFESSIONS: This activity qualifies for 12.0 live or 11.75 self-study continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.

Only credits listed are approved. For any other credit inquiries (i.e. state specific or others not listed), please contact cecmi@cmieducation.org or 800-844-8260 BEFORE the event. Additional credit inquiries submitted after the date of the event will not be honored, per board regulations. For all other inquiries, please contact info@pesi.com.

Faculty

  • Joseph Wegmann, Pharm.D., LCSW
    • Joseph Wegmann, Doctor of Pharmacy, LCSW is a licensed clinical social worker and a Doctor of Pharmacy specializing in psychopharmacology. He has presented psychopharmacology seminars to thousands of healthcare professionals throughout 46 states, and he maintains an active psychotherapy practice specializing in the treatment of depression and anxiety. In addition, Dr. Wegmann has served as adjunct professor of psychopharmacology in the Southern University of New Orleans master of social work program for 17 years.

Course Materials

  • Buy It/Rent It Manual (101 pages)
  • Additional_Participant_CE_Request_Form (7 pages)